Summary:
Currently, no drugs are globally approved for the treatment of non-alcoholic steatohepatitis (NASH). First-line of treatment is lifestyle intervention to achieve weight loss and treatment of other co-existing conditions like high blood pressure and diabetes. But other effective treatments for patients with NASH are needed. That's why Tandem Clinical Research is looking for volunteers with non-alcoholic steatohepatitis (NASH) for a research study of an investigational medication.
To qualify, you must:
· Be 18 years of age or older
· Have a diagnosis of NASH
Qualified Participants May Receive:
Qualified participants will receive study-related medication and care. Compensation for time and travel may be available. To learn more or schedule an appointment, contact Tandem Clinical Research today!